2021
DOI: 10.1186/s13000-021-01088-1 View full text |Buy / Rent full text
|
|

Abstract: Background TWIST1 and CD105, which contribute to tumor malignancy, are overexpressed in cancers. Accordingly, TWIST1 enhances epithelial-to-mesenchymal transition (EMT) and promotes the formation of cancer stem cells (CSCs). Also, CD105 is a neoangiogenesis marker in endothelial cells, which is introduced as a CSC marker in tumoral epithelial cells in several types of cancers. The present study was aimed to investigate expressions of TWIST1 and CD105 in colorectal cancer (CRC) patients. … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
1
0

Publication Types

Select...

Relationship

0
0

Authors

Journals